REGULATED PRESS RELEASE
News
-
-
PRESS RELEASE
H1 2024 REVENUE: EUR 204.4m - RETAIL SALES OF DIRECTLY-OPERATED STORES EQUAL TO THE HIGH LEVEL OF H1 2023 - CONFIRMED RETURN TO GROWTH IN H2
Roche Bobois SA reports H1 2024 revenue of €204.4m, down -7.8%. Anticipates return to growth in second half. Focuses on international expansion in North America and Asia -
-
-
-
PRESS RELEASE
InTiCa Systems SE: Strategic expansion of the product portfolio and repositioning of the segments
InTiCa Systems SE announces strategic expansion of product portfolio and repositioning of segments in Annual Report 2023, focusing on Mobility and Industry & Infrastructure segments for future growth -
PRESS RELEASE
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors -
-
-
PRESS RELEASE
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
Applied DNA Sciences announces $1.04 million contract with U.S. Defense Logistics Agency for counterfeit mitigation and product verification programs specific to FSC 5962 microcircuits. Continues support since 2014
